A federal agency is asking the public to submit scientific data on the potential benefits of marijuana for people with acute pain and migraine headaches.
In two notices published in the Federal Register this month, the Agency for Healthcare Research and Quality (AHRQ) said it is conducting a review of treatment approaches to the two health conditions, with a particular focus on alternatives to opioids. Both listings specifically include cannabis as an example of a therapy the government would like help investigating.
The agency, which is a division of the Department of Health and Human Services, said it “is dedicated to identifying as many studies as possible that are relevant to the questions for each of its reviews.”
“In order to do so, we are supplementing the usual manual and electronic database searches of the literature by requesting information from the public (e.g., details of studies conducted).”